DR. CARRIE A MIHORDIN (D.O.) – Rheumatology Physician, NPI 1548458672
Rheumatology Physician
Main info
Doctor Profile
Contacts
Profile Insights
NPPES metrics only — not quality of care.
50 RHEUMATOLOGY in KS
Loading map...
Provider Addresses for DR. CARRIE A MIHORDIN (D.O.)
West 119th Street, Overland Park, Johnson County, Kansas, 66251, United States
STE 209, MID-AMERICA RHEUMATOLOGY CONSULTANTS
OVERLAND PARK, KS 662093721
Phone: (913) 661-9980
Fax: (913) 661-9173
Mailing address matches the actual address.
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 41 Open Payments records for all available years, with a total value of $927.
Total Amount is formed as General ($927) + Research ($0) + Ownership ($0) = $927.
Last reported payment date: 2024-11-05 • Largest payer in this snapshot: ABBVIE INC. ($261).
Total Amount
$927
General + Research + Ownership
Payments
41
Total payment records
General Amount
$927
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-11-05
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| ABBVIE INC. | $261 |
| Janssen Biotech, Inc. | $145 |
| Amgen Inc. | $93 |
| PFIZER INC. | $88 |
| Organon LLC | $50 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2011-08-17
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20110817000397 | I | Rheumatology | KS | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 66,840 | 27 | $0 |
| J3262 | Injection, tocilizumab, 1 mg | 60,800 | 23 | $0 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 21,100 | 45 | $0 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,290 | 29 | $0 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,760 | 32 | $0 |
Insurance plans in this area (ZIP 66209)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| RHEUMATOLOGY | KS | 96415 | Infusion of chemotherapy into a vein | 189 | 82 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| R H E U M A T O L O G Y | KS | |
| Internal Medicine | WI | |
| R H E U M A T O L O G Y | IL | |
| - | KS |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.